Data companies band together to form RWE Alliance
Can an industry coalition help craft policy to support the use of Real-World Evidence? Five prominent real-world data and analytics companies are betting on it, launching the RWE Alliance.
How Tempus’ corporate counsel views healthcare innovation: A Q&A with Maggie Huston
In a wide-ranging interview, Maggie Huston, associate general counsel for precision medicine company Tempus, discusses how to balance innovation with safety as the FDA grapples with AI/ML and new, more complex technology, as well how her company quickly reacted to Covid-19.
Heard at HLTH 2024: Insights from Innovative Healthcare Executives
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
Funding roundup: Element Science raises $145.6M for wearable defibrillators
Business may have slowed for many, but several biotech and digital health startups are still bringing in venture capital dollars. Here are a few biotech and healthcare companies that announced funding rounds this week.
Chicago precision medicine startup Tempus nabs $200M for expansion
The company, which is led by Groupon co-founder Eric Lefkofsky, is focused on the collection and analysis of molecular and clinical data.
Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer
The feasibility study was meant to see whether personalized cancer genetic sequencing and drug sensitivity recommendations could be done in a "clinically reasonable amount of time."
Rock Health: Digital health investing has already surpassed record-breaking 2017
In 2018 alone, ten companies have inked mega-deals of more than $100 million including Livongo, 23andMe and American Well.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Following $110M fundraise, Tempus reveals mobile app to give doctors access to clinical data
Called Tempus Labs, the Chicago startup's new tool is currently available and allows physicians to securely access patient information at the point of care.
Tempus unveils a standalone tool for structuring clinical data at scale
Why do some patients respond to immuno-oncology drugs when others don’t? Tempus developed a tool to aggregate the phenotypic, therapeutic, and outcome and response data to help physicians answer this question.
Groupon cofounder’s healthcare startup Tempus closes $70 million Series C round
The biotechnology company is led by Groupon cofounder and chairman Eric Lefkofsky. The latest round brings the startup's total funding to $130 million.
Why Groupon’s cofounder is diving head first into healthcare
After a career spent in tech, Eric Lefkofsky's mission took an unexpected twist when his wife was diagnosed with cancer: "I was just amazed at how little technology had permeated her care and I became infatuated with trying to understand why," he said.
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.